Cholesterol and the risk of renal dysfunction in apparently healthy men.
暂无分享,去创建一个
J. Buring | K. Rexrode | R. Glynn | E. Schaeffner | T. Kurth | G. Curhan | C. Baigent | J. Gaziano
[1] Avram Mm. Similarities between glomerular sclerosis and atherosclerosis in human renal biopsy specimens: a role for lipoprotein glomerulopathy. , 1989 .
[2] J. Mustonen,et al. Hypertriglyceridaemia and hyperuricaemia are risk factors for progression of IgA nephropathy. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[3] D. Ford,et al. Validity of physicians' self-reports of cardiovascular disease risk factors. , 1993, Annals of epidemiology.
[4] Z. Varghese,et al. LIPID NEPHROTOXICITY IN CHRONIC PROGRESSIVE GLOMERULAR AND TUBULO-INTERSTITIAL DISEASE , 1982, The Lancet.
[5] R. Collins,et al. PROBLEMS WITH MAILED BLOOD IN LARGE-SCALE EPIDEMIOLOGIC STUDIES AND METHODS OF CORRECTION , 1993 .
[6] B. Kasiske,et al. Lipids and progressive glomerulosclerosis. A model analogous to atherosclerosis. , 1988, American journal of nephrology.
[7] V. Manninen,et al. Effects of hypertension and dyslipidemia on the decline in renal function. , 1995, Hypertension.
[8] O. Wiklund,et al. Cholesterol: a renal risk factor in diabetic nephropathy? , 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[9] B. Kasiske,et al. Pharmacologic Treatment of Hyperlipidemia Reduces Glomerular Injury in Rat 5/6 Nephrectomy Model of Chronic Renal Failure , 1988, Circulation research.
[10] N. Madias,et al. Serum creatinine as an index of renal function: new insights into old concepts. , 1992, Clinical chemistry.
[11] A. Kliger,et al. Chronic renal insufficiency: current understandings and their implications. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[12] M. H. Gault,et al. Prediction of creatinine clearance from serum creatinine. , 1975, Nephron.
[13] F. Schena,et al. Treatment of glomerulonephritides associated with hepatitis C virus infection. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[14] H. Mulec,et al. Complex apolipoprotein B-containing lipoprotein particles are associated with a higher rate of progression of human chronic renal insufficiency. , 1998, Journal of the American Society of Nephrology : JASN.
[15] A. Levey,et al. Cardiovascular disease and chronic renal disease: a new paradigm. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[16] J. Manson,et al. Baseline characteristics of participants in the Physicians' Health Study: a randomized trial of aspirin and beta-carotene in U.S. physicians. , 1991, American journal of preventive medicine.
[17] R. Wolfe,et al. I. The USRDS and its products. , 1999, American Journal of Kidney Diseases.
[18] W. Keane,et al. The role of lipids in renal disease: future challenges. , 2000, Kidney international. Supplement.
[19] C. Baigent,et al. Study of Heart and Renal Protection (SHARP). , 2003, Kidney international. Supplement.
[20] J. Coresh,et al. Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study. , 2000, Kidney international.
[21] David Roth,et al. A simplified equation to predict glomerular filtration rate from serum creatinine , 2000 .
[22] M. Avram. Similarities between glomerular sclerosis and atherosclerosis in human renal biopsy specimens: a role for lipoprotein glomerulopathy. , 1989, The American journal of medicine.
[23] B. Kasiske,et al. Renal injury of diet-induced hypercholesterolemia in rats. , 1990, Kidney international.
[24] G. Remuzzi,et al. Progression, remission, regression of chronic renal diseases , 2001, The Lancet.
[25] B. Kasiske,et al. Effect of lipid reduction on the progression of renal disease: a meta-analysis. , 2001, Kidney international.
[26] A. Garg,et al. Albuminuria and renal insufficiency prevalence guides population screening: results from the NHANES III. , 2003, Kidney international.
[27] H. Oda,et al. Recent advances in statins and the kidney. , 1999, Kidney international. Supplement.
[28] W. Keane. Lipids and the kidney. , 1994, Kidney international.
[29] E. Rimm,et al. Validity of Self‐Reported Waist and Hip Circumferences in Men and Women , 1990, Epidemiology.
[30] Cockcroft Dw,et al. Prediction of Creatinine Clearance from Serum Creatinine , 1976 .
[31] J. Coresh,et al. Microalbuminuria in the US population: third National Health and Nutrition Examination Survey. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[32] H. Wedel,et al. Lipoprotein abnormalities are associated with increased rate of progression of human chronic renal insufficiency. , 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[33] Final report on the aspirin component of the ongoing Physicians' Health Study. , 1989, The New England journal of medicine.
[34] J. Manson,et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. , 1996, The New England journal of medicine.
[35] W. Willett,et al. Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women. , 1986, American journal of epidemiology.
[36] S. Silbiger,et al. The impact of gender on the progression of chronic renal disease. , 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[37] A. Albertazzi,et al. Lipids in the progression of chronic renal failure. , 1992, Nephron.
[38] T. Louis,et al. Long-term effects of antihypertensive agents on proteinuria and renal function. , 1995, Archives of internal medicine.
[39] J. Mckenney,et al. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). , 2001, JAMA.
[40] D. Bates,et al. Diabetes, hemoglobin A(1c), cholesterol, and the risk of moderate chronic renal insufficiency in an ambulatory population. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.